Relmada Therapeutics (4E2.F) Q3 2025 Earnings

Aug 7Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.67
-0.53
-0.39
-0.26

Details

Expected EPS
-0.3939072
Actual EPS
-0.25689599999999996
Surprise EPS
0.14
Surprise Percent
+34.78%

Description

⁨Relmada Therapeutics⁩ (⁦4E2.F⁩) has reported earnings of ⁦-0.25689599999999996⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts